An XBB booster was associated with a 41% reduced risk of JN.1 infection.
XBB booster offers protection against JN.1 infections, hospital cases, new data show
More from COVID-19More posts in COVID-19 »
- Genetic vulnerability, air pollution may raise risk of COVID infection, severe outcomes
- COVID 2024-25 vaccines 33% protective against emergency room or urgent care visits, data reveal
- Paxlovid may better cut risk of severe COVID outcomes in asthma patients than molnupiravir
- US flu season shows signs of peak